Skip to main content
Erschienen in: Medical Oncology 4/2011

01.12.2011 | Original Paper

Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women

verfasst von: K. O. Hajian-Tilaki, A. R. Gholizadehpasha, S. Bozorgzadeh, E. Hajian-Tilaki

Erschienen in: Medical Oncology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Both obesity and breast cancer incidence increased dramatically during two recent decades in a rapidly changing society in northern Iran. In this study, we examined the ability of body mass index (BMI) and waist circumference (WC) as predictor biomarkers of breast cancer risk in Iranian women. In a case–control study of 100 new cases of histological confirmed breast cancer and 200 age-matched controls, in Babol, we measured weight, height, waist and hip circumference at time of diagnosis with standard methods. The data of demographic, characteristics, reproductive and lifestyle factors were collected by interview. We used both regression and receiver operator characteristics (ROC) analysis to estimate the predictive ability of BMI and WC for breast cancer as estimated by area under the curve (AUC). The results showed a significant difference in the mean of weight, BMI and WC between patients and controls in pre- and postmenopausal women (P < 0.001). While after adjusting for BMI, no longer an association between WC and breast cancer was found. The overall accuracy of observed BMI and WC were 0.79 (95% CI: 0.74–0.84) and 0.68 (95% CI: 0.61–0.74), respectively. The accuracy of BMI and WC were 0.82 (95% CI: 0.76–0.89), 0.75(0.67–0.83) for premenopausal and 0.77(0.68–0.85), 0.60 (0.50–0.71) for postmenopausal women, respectively. BMI and WC are predictor biomarkers of breast cancer risk in both pre- and postmenopausal Iranian women while after adjusting for BMI, no longer an association between WC and breast cancer was observed. These findings imply to perform breast cancer screening program in women with a higher BMI and WC.
Literatur
2.
Zurück zum Zitat Parkin DM, Bary FL, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37:s4–s66.PubMedCrossRef Parkin DM, Bary FL, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37:s4–s66.PubMedCrossRef
3.
Zurück zum Zitat Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekzadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an International prospective. Asian Pac J Cancer Prev. 2005;6:359–63.PubMed Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekzadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an International prospective. Asian Pac J Cancer Prev. 2005;6:359–63.PubMed
4.
Zurück zum Zitat Cancer Control Office of Ministry of Health: Iranian annual cancer registration report: 2003. Tehran, Ministry of Health publication 2005. [in Persian]. Cancer Control Office of Ministry of Health: Iranian annual cancer registration report: 2003. Tehran, Ministry of Health publication 2005. [in Persian].
5.
Zurück zum Zitat Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24–7.PubMed Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24–7.PubMed
6.
Zurück zum Zitat Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R. Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population based cancer registry. East Mediterr Health J. 2009;15(9):1426–31. Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R. Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population based cancer registry. East Mediterr Health J. 2009;15(9):1426–31.
7.
Zurück zum Zitat Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years in the north of Iran: a population study and regression approach. Obes Rev. 2007;8(1):3–10.PubMedCrossRef Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years in the north of Iran: a population study and regression approach. Obes Rev. 2007;8(1):3–10.PubMedCrossRef
8.
Zurück zum Zitat Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2004;111(5):762–71.PubMedCrossRef Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2004;111(5):762–71.PubMedCrossRef
9.
Zurück zum Zitat Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10(1):15–32.PubMedCrossRef Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10(1):15–32.PubMedCrossRef
10.
Zurück zum Zitat Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, et al. Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol. 1999;28(6):1026–31.PubMedCrossRef Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, et al. Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol. 1999;28(6):1026–31.PubMedCrossRef
11.
Zurück zum Zitat Bruning BF, Bonfrer JM, Hart AA, van Noord PA, Van der Hoeven H, Collette HJ, Battermann JJ, et al. Body measurements estrogen availability and the risk of human breast cancer: a case- control study. Int J Cancer. 1992;51(1):14–9.PubMedCrossRef Bruning BF, Bonfrer JM, Hart AA, van Noord PA, Van der Hoeven H, Collette HJ, Battermann JJ, et al. Body measurements estrogen availability and the risk of human breast cancer: a case- control study. Int J Cancer. 1992;51(1):14–9.PubMedCrossRef
12.
Zurück zum Zitat Nemesure B, Wu SY, Hennis A, Leske MC. Barbados National Cancer Study Group. Body size and breast cancer in a black population–the Barbados National Cancer Study. Cancer Cause Control. 2009;20(3):387–94.CrossRef Nemesure B, Wu SY, Hennis A, Leske MC. Barbados National Cancer Study Group. Body size and breast cancer in a black population–the Barbados National Cancer Study. Cancer Cause Control. 2009;20(3):387–94.CrossRef
13.
Zurück zum Zitat Goodman MT, Nomura AM, Wilkens LR, Hankin J. The Association of diet, obesity, and breast cancer in Hawaii. Cancer Epidemiol Biomarkers Prev. 1992;1(4):269–75.PubMed Goodman MT, Nomura AM, Wilkens LR, Hankin J. The Association of diet, obesity, and breast cancer in Hawaii. Cancer Epidemiol Biomarkers Prev. 1992;1(4):269–75.PubMed
14.
Zurück zum Zitat Chow LW, Lui KL, Chan JC, Chan TC, Ho PK, Lee WY, et al. Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg. 2005;28(3):179–84.PubMedCrossRef Chow LW, Lui KL, Chan JC, Chan TC, Ho PK, Lee WY, et al. Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg. 2005;28(3):179–84.PubMedCrossRef
15.
Zurück zum Zitat Osório-Costa F, Rocha GZ, Dias MM, Carvalheira JB. Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol. 2009;53(2):213–26.PubMedCrossRef Osório-Costa F, Rocha GZ, Dias MM, Carvalheira JB. Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol. 2009;53(2):213–26.PubMedCrossRef
16.
Zurück zum Zitat Carter JC, Church FC. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res. 2009;. doi:10.1155//345320. Carter JC, Church FC. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res. 2009;. doi:10.​1155/​/​345320.
17.
Zurück zum Zitat Tilg H, Moshen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–83.PubMedCrossRef Tilg H, Moshen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–83.PubMedCrossRef
18.
Zurück zum Zitat Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol. 2005;115:911–9.PubMedCrossRef Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol. 2005;115:911–9.PubMedCrossRef
19.
Zurück zum Zitat Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 2007;9:R15. doi:10.1186/bcrl648.PubMedCrossRef Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 2007;9:R15. doi:10.​1186/​bcrl648.PubMedCrossRef
20.
Zurück zum Zitat Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta. 2002;1592(2):107–16.PubMed Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta. 2002;1592(2):107–16.PubMed
21.
Zurück zum Zitat Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114:71–83.PubMedCrossRef Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114:71–83.PubMedCrossRef
22.
Zurück zum Zitat Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, et al. Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer. 2009;100(4):578–82.PubMedCrossRef Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, et al. Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer. 2009;100(4):578–82.PubMedCrossRef
23.
Zurück zum Zitat Hajian-Tilaki KO, Kaveh-Ahangar T. Reproductive factors associated with breast cancer risk in northern Iran. Med Oncol, published online:3 Apr 2010. Hajian-Tilaki KO, Kaveh-Ahangar T. Reproductive factors associated with breast cancer risk in northern Iran. Med Oncol, published online:3 Apr 2010.
24.
Zurück zum Zitat She XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, et al. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer. 2001;94(3):449–55.CrossRef She XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, et al. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer. 2001;94(3):449–55.CrossRef
25.
Zurück zum Zitat Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancer. Am J Clin Nutr. 1996;63(3 Supll):437S–41S.PubMed Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancer. Am J Clin Nutr. 1996;63(3 Supll):437S–41S.PubMed
26.
Zurück zum Zitat Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.PubMedCrossRef Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.PubMedCrossRef
27.
Zurück zum Zitat Hu YH, Nagata C, Shimizu H, Kaneda N, Kashiki Y. Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat. 1997;43(1):65–72.PubMedCrossRef Hu YH, Nagata C, Shimizu H, Kaneda N, Kashiki Y. Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat. 1997;43(1):65–72.PubMedCrossRef
28.
Zurück zum Zitat Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1686–91.PubMedCrossRef Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1686–91.PubMedCrossRef
29.
Zurück zum Zitat Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;1128–43. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;1128–43.
30.
Zurück zum Zitat Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001;92(4):720–9.PubMedCrossRef Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001;92(4):720–9.PubMedCrossRef
31.
Zurück zum Zitat Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol. 2007;17:304–12.PubMedCrossRef Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol. 2007;17:304–12.PubMedCrossRef
32.
Zurück zum Zitat Wu MH, Chou YC, Yu JC, Yu CP, Wu CC, Chu CM, et al. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11889 women in a low-incidence area. Ann Epidemiol. 2006;16:223–9.PubMedCrossRef Wu MH, Chou YC, Yu JC, Yu CP, Wu CC, Chu CM, et al. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11889 women in a low-incidence area. Ann Epidemiol. 2006;16:223–9.PubMedCrossRef
33.
Zurück zum Zitat Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer. 1997;80:725–31.PubMedCrossRef Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer. 1997;80:725–31.PubMedCrossRef
34.
Zurück zum Zitat Yoo KY, Kim Y, Park SK, Kang D. Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. Asian Pac J Cancer Prev. 2006;7:679–82.PubMed Yoo KY, Kim Y, Park SK, Kang D. Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. Asian Pac J Cancer Prev. 2006;7:679–82.PubMed
35.
Zurück zum Zitat Surekha D, Sailaja D, Rao DN, Padma T, Raghunadharao D, Vishnupriya S. Association of CPYP1A1*2 polymorphisms with breast cancer risk: a case control study. Indian J Med Sci. 2009;63(1):13–20.PubMedCrossRef Surekha D, Sailaja D, Rao DN, Padma T, Raghunadharao D, Vishnupriya S. Association of CPYP1A1*2 polymorphisms with breast cancer risk: a case control study. Indian J Med Sci. 2009;63(1):13–20.PubMedCrossRef
36.
Zurück zum Zitat Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, et al. Association between breast cancer susceptibility gene polymorphism and clinicopathological features. Clin Cancer Res. 2004;10:124–30.PubMedCrossRef Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, et al. Association between breast cancer susceptibility gene polymorphism and clinicopathological features. Clin Cancer Res. 2004;10:124–30.PubMedCrossRef
37.
Zurück zum Zitat Mannisto S, Pietinen P, Pyy M, et al. Body size indicators and risk of breast cancer to menopause and estrogen-receptor status. Int J Cancer. 1996;68:8–13.PubMedCrossRef Mannisto S, Pietinen P, Pyy M, et al. Body size indicators and risk of breast cancer to menopause and estrogen-receptor status. Int J Cancer. 1996;68:8–13.PubMedCrossRef
38.
Zurück zum Zitat Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women. Am Cancer Soc. 1997;80:725–31. Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women. Am Cancer Soc. 1997;80:725–31.
39.
Zurück zum Zitat Franceschi S, Favero A, Vecchia EL, et al. Body size and risk of breast cancer before and after menopause. Int J Cancer. 1996;67:181–6.PubMedCrossRef Franceschi S, Favero A, Vecchia EL, et al. Body size and risk of breast cancer before and after menopause. Int J Cancer. 1996;67:181–6.PubMedCrossRef
40.
Zurück zum Zitat Petrek JA, Peters M, Cirrincione C, Bajorunas D. Is body fat topography a risk factor for breast cancer? Ann Intern Med. 1993;118(5):356–62.PubMed Petrek JA, Peters M, Cirrincione C, Bajorunas D. Is body fat topography a risk factor for breast cancer? Ann Intern Med. 1993;118(5):356–62.PubMed
41.
Zurück zum Zitat Huang Z, Willent WC, Colditz GA, et al. Waist circumference, waist hip ratio and risk of breast cancer in the Nurses Health Study. Am J Epidemiol. 1999;150:1316–24.PubMed Huang Z, Willent WC, Colditz GA, et al. Waist circumference, waist hip ratio and risk of breast cancer in the Nurses Health Study. Am J Epidemiol. 1999;150:1316–24.PubMed
Metadaten
Titel
Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women
verfasst von
K. O. Hajian-Tilaki
A. R. Gholizadehpasha
S. Bozorgzadeh
E. Hajian-Tilaki
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9629-6

Weitere Artikel der Ausgabe 4/2011

Medical Oncology 4/2011 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.